Paroxetine Impurity 12 | CAS 153173-08-1 - Request Quote
Paroxetine Impurity 12
| SZ CAT No: | SZ-P012046 |
| CAS No | 153173-08-1 |
| Mol.F. | C14H14FNO4 |
| Mol.Wt. | 279.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Paroxetine Impurity 12 is chemically Methyl (3S,4R)-4-(4-fluorophenyl)-1-methyl-2,6-dioxopiperidine-3-carboxylate. Paroxetine Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Paroxetine Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Paroxetine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 153173-08-1
Purchase 153173-08-1
Order 153173-08-1
Enquire 153173-08-1
price of 153173-08-1
153173-08-1 Supplier
153173-08-1 Manufacturer
153173-08-1 Exporter
buy high quality Paroxetine Impurity 12
Purchase Paroxetine Impurity 12
Paroxetine Impurity 12 suppliers
Paroxetine Impurity 12 manufacturers
Paroxetine Impurity 12 price
Order Paroxetine Impurity 12
Enquire Paroxetine Impurity 12
Paroxetine Impurity 12 cost
Paroxetine Impurity 12 Supplier
Paroxetine Impurity 12 Distributor
Paroxetine Impurity 12 for Method Validation
Paroxetine Reference Standard
Paroxetine Impurity 12 for ANDA Filing
Paroxetine Impurity 12 for Forced Degradation Studies
Paroxetine Impurity 12 Identification Standards
Paroxetine Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.